NCT04980443View on ClinicalTrials.gov

Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors

NACompletedINTERVENTIONAL
Enrollment

809

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

October 1, 2022

Study Completion Date

November 1, 2022

Conditions
Colorectal CancerColorectal NeoplasmsColorectal CarcinomaColorectal PolypColorectal Adenoma
Interventions
DIAGNOSTIC_TEST

CELTiC test

The CELTiC test is a blood-based test consisting of four mRNA markers and the risk factor age.

Trial Locations (4)

40138

Università di Bologna, Bologna

1105 AZ

Amsterdam UMC, locatie Academisch Medisch Centrum, Amsterdam

Bergman Clinics, Amsterdam

3015CN

Erasmus University Medical Center, Rotterdam

All Listed Sponsors
collaborator

Bergman Clinics

OTHER

collaborator

University of Bologna

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT04980443 - Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors | Biotech Hunter | Biotech Hunter